Regenxbio
RGNX
RGNX
177 hedge funds and large institutions have $1.87B invested in Regenxbio in 2018 Q2 according to their latest regulatory filings, with 81 funds opening new positions, 51 increasing their positions, 33 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
48% more funds holding
Funds holding: 120 → 177 (+57)
44% more call options, than puts
Call options by funds: $15.3M | Put options by funds: $10.6M
10.83% more ownership
Funds ownership: 70.66% → 81.49% (+11%)
Holders
177
Holding in Top 10
5
Calls
$15.3M
Puts
$10.6M
Top Buyers
| 1 | +$143M | |
| 2 | +$60.2M | |
| 3 | +$41.2M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$31.2M |
| 5 |
HCM
Highline Capital Management
New York
|
+$25.1M |
Top Sellers
| 1 | -$53.5M | |
| 2 | -$40.9M | |
| 3 | -$28.5M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$28M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$23.7M |